title: 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation.
abstract: Rhythmic cortical neuronal oscillations in the gamma frequency band (30-80 Hz, gamma oscillations) have been associated with cognitive processes such as sensory perception and integration, attention, learning, and memory. Gamma oscillations are disrupted in disorders for which cognitive deficits are hallmark symptoms such as schizophrenia and Alzheimer's disease.In vitro, various neurotransmitters have been found to modulate gamma oscillations. Serotonin(5-HT) has long been known to be important for both behavioural and cognitive functions such as learning and memory. Multiple 5-HT receptor subtypes are expressed in the CA3 region of the hippocampus and high doses of 5-HT reduce the power of induced gamma oscillations.Hypothesizing that 5-HT may have cell- and receptor subtype-specific modulatory effects, we investigated the receptor subtypes, cell types and cellular mechanisms engaged by 5-HT in the modulation of gamma oscillations in mice and rats. We found that 5-HT decreases the power of kainate-induced hippocampal gamma oscillations in both species via the 5-HT1A receptor subtype. Whole-cell patch clamp recordings demonstrated that this decrease was caused by a hyperpolarization of CA3 pyramidal cells and a reduction of their firing frequency, but not by alteration of inhibitory neurotransmission. Finally, our results show that the effect on pyramidal cells is mediated via the G protein-coupled receptor inwardly rectifying potassium channel Kir3.Our findings suggest this novel cellular mechanism as a potential target for therapies that are aimed at alleviating cognitive decline by helping the brain to maintain or re-establish normal gamma oscillation levels in neuropsychiatric and neurodegenerative disorders.
authors.affiliation: Neuronal Oscillations Laboratory, Division for Neurogeriatrics, Center for Alzheimer Research, Dept. NVS, Karolinska Institutet, 14186, Stockholm, Sweden Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, 20892, USA.
authors.forename: April
authors.initials: A
authors.lastname: Johnston
authors.affiliation: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, 20892, USA.
authors.forename: Chris J
authors.initials: CJ
authors.lastname: McBain
authors.affiliation: Neuronal Oscillations Laboratory, Division for Neurogeriatrics, Center for Alzheimer Research, Dept. NVS, Karolinska Institutet, 14186, Stockholm, Sweden andre.fisahn@ki.se.
authors.forename: André
authors.initials: A
authors.lastname: Fisahn
mesh_terms: D000818:Animals; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D007608:Kainic Acid / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D017966:Pyramidal Cells / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000494:pharmacology*
chemical_list: D018690:Excitatory Amino Acid Agonists; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D058825:Serotonin 5-HT1 Receptor Agonists; D044282:Receptor, Serotonin, 5-HT1A; D012701:Serotonin; D007608:Kainic Acid
references.citation: J Neurosci. 1996 Nov 15;16(22):7137-50
references.pmid: 8929423
references.citation: Br J Pharmacol. 2012 Dec;167(7):1480-91
references.pmid: 22817643
references.citation: Neuropharmacology. 2005 Mar;48(3):381-90
references.pmid: 15721170
references.citation: Behav Brain Res. 2008 Dec 16;195(1):54-77
references.pmid: 18394726
references.citation: Eur J Pharmacol. 2002 Oct 25;453(2-3):217-21
references.pmid: 12398907
references.citation: Neurobiol Learn Mem. 2014 Apr;110:72-80
references.pmid: 24423786
references.citation: J Neurochem. 2001 Feb;76(3):865-71
references.pmid: 11158258
references.citation: J Neurosci. 2004 Oct 27;24(43):9658-68
references.pmid: 15509753
references.citation: Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2395-401
references.pmid: 22826340
references.citation: Br J Pharmacol. 2002 Aug;136(7):1072-8
references.pmid: 12145108
references.citation: J Neurosci. 2011 Jun 8;31(23):8464-75
references.pmid: 21653851
references.citation: Neuron. 1997 Sep;19(3):687-95
references.pmid: 9331358
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14476-81
references.pmid: 9826725
references.citation: Science. 1986 Dec 5;234(4781):1261-5
references.pmid: 2430334
references.citation: Hippocampus. 2012 Apr;22(4):790-801
references.pmid: 21538661
references.citation: PLoS One. 2012;7(7):e40906
references.pmid: 22815864
references.citation: Neuron. 2003 Jan 23;37(2):311-22
references.pmid: 12546825
references.citation: Curr Opin Neurobiol. 2007 Apr;17(2):154-60
references.pmid: 17306527
references.citation: Neurosci Lett. 2002 May 10;324(1):1-4
references.pmid: 11983280
references.citation: Hippocampus. 2009 Mar;19(3):273-88
references.pmid: 19173289
references.citation: Nature. 1998 Jul 9;394(6689):186-9
references.pmid: 9671302
references.citation: J Neurosci. 2012 Jan 11;32(2):423-35
references.pmid: 22238079
references.citation: J Neurosci. 2006 Apr 19;26(16):4289-97
references.pmid: 16624949
references.citation: Biol Psychiatry. 2008 Apr 15;63(8):744-7
references.pmid: 18083143
references.citation: Neurochem Int. 1999 May;34(5):359-72
references.pmid: 10397363
references.citation: Neuron. 2009 May 28;62(4):566-77
references.pmid: 19477157
references.citation: J Neurosci. 2010 Feb 17;30(7):2694-9
references.pmid: 20164353
references.citation: Nature. 2009 Jun 4;459(7247):663-7
references.pmid: 19396156
references.citation: Brain Res. 2003 Jan 3;959(1):58-67
references.pmid: 12480158
references.citation: J Neurophysiol. 2002 May;87(5):2490-504
references.pmid: 11976386
references.citation: J Neurosci. 2001 Mar 1;21(5):1727-38
references.pmid: 11222662
references.citation: Psychopharmacology (Berl). 2012 May;221(2):261-72
references.pmid: 22147258
references.citation: Nature. 2009 Nov 19;462(7271):353-7
references.pmid: 19924214
references.citation: J Physiol. 2010 Apr 15;588(Pt 8):1241-9
references.pmid: 20156850
references.citation: Br J Pharmacol. 1998 Jul;124(6):1238-44
references.pmid: 9720796
references.citation: Nature. 2009 Jun 4;459(7247):698-702
references.pmid: 19396159